Amgen IncNASDAQ:AMGN
- LAST PRICE314.7200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots314.7500/ 10
- Ask / Lots316.0000/ 1
- Open / Previous Close314.6300 / 314.7200
- Day Range
- 52 Week Range
- Volume2,367,819
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMGN |
|---|---|---|
| 09:32 ET | 45059 | 314.755 |
| 09:34 ET | 10241 | 312.335 |
| 09:36 ET | 8938 | 312.93 |
| 09:38 ET | 8088 | 311.94 |
| 09:39 ET | 11559 | 310.95 |
| 09:41 ET | 3679 | 311.56 |
| 09:43 ET | 4347 | 310.85 |
| 09:45 ET | 10542 | 311.355 |
| 09:48 ET | 13150 | 311.83 |
| 09:50 ET | 9865 | 311.645 |
| 09:52 ET | 14850 | 311.55 |
| 09:54 ET | 12534 | 312.145 |
| 09:56 ET | 24499 | 311.935 |
| 09:57 ET | 3843 | 311.75 |
| 09:59 ET | 4198 | 311.74 |
| 10:01 ET | 7861 | 312.15 |
| 10:03 ET | 6902 | 312.72 |
| 10:06 ET | 4000 | 313.19 |
| 10:08 ET | 6161 | 313.09 |
| 10:10 ET | 3572 | 312.57 |
| 10:12 ET | 2797 | 312.72 |
| 10:14 ET | 2627 | 312.725 |
| 10:15 ET | 6287 | 312.58 |
| 10:17 ET | 12527 | 312.19 |
| 10:19 ET | 1807 | 312.56 |
| 10:21 ET | 4471 | 312.34 |
| 10:24 ET | 3326 | 312.28 |
| 10:26 ET | 2738 | 312.64 |
| 10:28 ET | 8290 | 312.53 |
| 10:30 ET | 1414 | 312.4882 |
| 10:32 ET | 4849 | 312.66 |
| 10:33 ET | 5082 | 312.55 |
| 10:35 ET | 10199 | 312.38 |
| 10:37 ET | 3813 | 312.315 |
| 10:39 ET | 8388 | 311.935 |
| 10:42 ET | 6675 | 312.0149 |
| 10:44 ET | 3676 | 312.6069 |
| 10:46 ET | 3969 | 313.18 |
| 10:48 ET | 7183 | 312.725 |
| 10:50 ET | 2830 | 313 |
| 10:51 ET | 5268 | 312.7475 |
| 10:53 ET | 3845 | 312.51 |
| 10:55 ET | 10848 | 312.61 |
| 10:57 ET | 3148 | 312.72 |
| 11:00 ET | 13105 | 312.65 |
| 11:02 ET | 5864 | 312.395 |
| 11:04 ET | 5492 | 312.095 |
| 11:06 ET | 5330 | 312.75 |
| 11:08 ET | 4295 | 312.7 |
| 11:09 ET | 7765 | 312.99 |
| 11:11 ET | 4937 | 313.17 |
| 11:13 ET | 14366 | 313.22 |
| 11:15 ET | 11215 | 313.02 |
| 11:18 ET | 7926 | 313.02 |
| 11:20 ET | 11084 | 312.9475 |
| 11:22 ET | 5156 | 313.38 |
| 11:24 ET | 2386 | 313.21 |
| 11:26 ET | 4637 | 313.5 |
| 11:27 ET | 4110 | 313.27 |
| 11:29 ET | 1498 | 313.555 |
| 11:31 ET | 5376 | 313.56 |
| 11:33 ET | 2034 | 313.6002 |
| 11:36 ET | 1200 | 313.715 |
| 11:38 ET | 8424 | 313.76 |
| 11:40 ET | 3523 | 313.47 |
| 11:42 ET | 6744 | 313.38 |
| 11:44 ET | 5786 | 313.35 |
| 11:45 ET | 3242 | 313.16 |
| 11:47 ET | 5200 | 312.92 |
| 11:49 ET | 3015 | 313.06 |
| 11:51 ET | 1725 | 313.25 |
| 11:54 ET | 1411 | 313.532 |
| 11:56 ET | 1005 | 313.91 |
| 11:58 ET | 1300 | 313.83 |
| 12:00 ET | 6307 | 314.4 |
| 12:02 ET | 4557 | 314.61 |
| 12:03 ET | 3540 | 314.485 |
| 12:05 ET | 4738 | 314.4 |
| 12:07 ET | 4828 | 314 |
| 12:09 ET | 4950 | 314.01 |
| 12:12 ET | 2485 | 313.905 |
| 12:14 ET | 3480 | 313.775 |
| 12:16 ET | 2156 | 313.535 |
| 12:18 ET | 14362 | 314.33 |
| 12:20 ET | 2530 | 314.145 |
| 12:21 ET | 4775 | 314.44 |
| 12:23 ET | 1838 | 314.425 |
| 12:25 ET | 2850 | 314.67 |
| 12:27 ET | 3896 | 314.5 |
| 12:30 ET | 6024 | 314.25 |
| 12:32 ET | 2900 | 314.11 |
| 12:34 ET | 1500 | 314.09 |
| 12:36 ET | 1860 | 314.21 |
| 12:38 ET | 1426 | 314.6 |
| 12:39 ET | 5671 | 314.9 |
| 12:41 ET | 1601 | 314.9 |
| 12:43 ET | 2942 | 314.955 |
| 12:45 ET | 1702 | 315.15 |
| 12:48 ET | 4607 | 315.055 |
| 12:50 ET | 3312 | 314.89 |
| 12:52 ET | 2127 | 314.8325 |
| 12:54 ET | 1449 | 314.91 |
| 12:56 ET | 2028 | 315.08 |
| 12:57 ET | 2744 | 315.015 |
| 12:59 ET | 5983 | 315.25 |
| 01:01 ET | 3435 | 315.3 |
| 01:03 ET | 3898 | 315.08 |
| 01:06 ET | 3461 | 314.9775 |
| 01:08 ET | 2092 | 315.035 |
| 01:10 ET | 5017 | 314.95 |
| 01:12 ET | 1470 | 314.84 |
| 01:14 ET | 3998 | 314.995 |
| 01:15 ET | 6770 | 315.1 |
| 01:17 ET | 2109 | 315.1 |
| 01:19 ET | 3073 | 314.92 |
| 01:21 ET | 3803 | 314.82 |
| 01:24 ET | 8732 | 314.2271 |
| 01:26 ET | 1400 | 314.27 |
| 01:28 ET | 1438 | 314.43 |
| 01:30 ET | 1664 | 314.49 |
| 01:32 ET | 6074 | 314.2842 |
| 01:33 ET | 3639 | 314.01 |
| 01:35 ET | 1072 | 313.965 |
| 01:37 ET | 4055 | 314.09 |
| 01:39 ET | 2135 | 314.13 |
| 01:42 ET | 3479 | 314.115 |
| 01:44 ET | 6501 | 314.08 |
| 01:46 ET | 3845 | 314.37 |
| 01:48 ET | 1104 | 314.405 |
| 01:50 ET | 1310 | 314.46 |
| 01:51 ET | 3645 | 314.44 |
| 01:53 ET | 5718 | 314.415 |
| 01:55 ET | 2388 | 314.49 |
| 01:57 ET | 1235 | 314.425 |
| 02:00 ET | 2918 | 314.515 |
| 02:02 ET | 1789 | 314.185 |
| 02:04 ET | 1100 | 314.01 |
| 02:06 ET | 2985 | 313.97 |
| 02:08 ET | 2471 | 313.8338 |
| 02:09 ET | 3734 | 313.89 |
| 02:11 ET | 1281 | 313.71 |
| 02:13 ET | 3011 | 313.735 |
| 02:15 ET | 1860 | 313.64 |
| 02:18 ET | 2272 | 313.79 |
| 02:20 ET | 2261 | 313.85 |
| 02:22 ET | 5071 | 313.77 |
| 02:24 ET | 1500 | 313.79 |
| 02:26 ET | 4362 | 313.79 |
| 02:27 ET | 2550 | 313.7 |
| 02:29 ET | 7133 | 313.78 |
| 02:31 ET | 1937 | 313.805 |
| 02:33 ET | 2830 | 313.875 |
| 02:36 ET | 3467 | 314.03 |
| 02:38 ET | 2317 | 313.905 |
| 02:40 ET | 4586 | 314.06 |
| 02:42 ET | 2119 | 314.025 |
| 02:44 ET | 4873 | 313.71 |
| 02:45 ET | 1963 | 313.67 |
| 02:47 ET | 3048 | 313.6301 |
| 02:49 ET | 1914 | 314 |
| 02:51 ET | 7422 | 314.005 |
| 02:54 ET | 12261 | 314.16 |
| 02:56 ET | 7669 | 314.41 |
| 02:58 ET | 4272 | 314.08 |
| 03:00 ET | 1771 | 314.14 |
| 03:02 ET | 3508 | 314.34 |
| 03:03 ET | 4371 | 314.83 |
| 03:05 ET | 7793 | 314.74 |
| 03:07 ET | 27358 | 314.38 |
| 03:09 ET | 5936 | 314.612 |
| 03:12 ET | 6768 | 314.94 |
| 03:14 ET | 17552 | 315.0998 |
| 03:16 ET | 3211 | 315.11 |
| 03:18 ET | 10316 | 315.04 |
| 03:20 ET | 5020 | 315.0946 |
| 03:21 ET | 2671 | 315.195 |
| 03:23 ET | 3305 | 315.25 |
| 03:25 ET | 2425 | 315.2625 |
| 03:27 ET | 6565 | 314.99 |
| 03:30 ET | 6874 | 315.1 |
| 03:32 ET | 4881 | 314.74 |
| 03:34 ET | 3011 | 315 |
| 03:36 ET | 2106 | 314.8758 |
| 03:38 ET | 5511 | 315.14 |
| 03:39 ET | 9494 | 314.89 |
| 03:41 ET | 5704 | 315.04 |
| 03:43 ET | 2704 | 315.01 |
| 03:45 ET | 7685 | 315.08 |
| 03:48 ET | 5279 | 315.2 |
| 03:50 ET | 4592 | 315.42 |
| 03:52 ET | 16151 | 315.755 |
| 03:54 ET | 16705 | 315.97 |
| 03:56 ET | 26080 | 314.8 |
| 03:57 ET | 20361 | 314.96 |
| 03:59 ET | 43841 | 314.72 |
Yesterday
DJ Amgen Gets FDA Approval for Small-Cell Lung-Cancer Treatment, from 7 hours ago by Dow Jones
7 hours ago by Dow JonesFDA APPROVES IMDELLTRA(TM) (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER, from 8 hours ago by Dow Jones
8 hours ago by Dow JonesDJ Roche's New Weight-Loss Data Shows Lilly Isn't Unbeatable in Obesity -- Barrons.com, from 16 hours ago by Dow Jones
16 hours ago by Dow Jones
May 15, 2024
AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024, from 6:45PM ET on Wednesday May 15, 2024 by Dow Jones
6:45PM ET on Wednesday May 15, 2024 by Dow Jones
May 9, 2024
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE, from 4:00PM ET on Thursday May 09, 2024 by Dow Jones
4:00PM ET on Thursday May 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amgen Inc | 171.1B | 45.0x | -0.22% |
Gilead Sciences Inc | 83.5B | 188.7x | +1.53% |
Novartis AG | 225.4B | 23.3x | -5.59% |
GSK plc | 94.6B | 16.2x | +6.39% |
AstraZeneca PLC | 237.5B | 38.0x | +17.52% |
Bristol-Myers Squibb Co | 90.3B | -14.2x | +4.90% |
Company Information
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.
Contact Information
- Headquarters
- One Amgen Center DriveTHOUSAND OAKS, CA, United States 91320
- Phone
- 805-447-1000
- Fax
- 805-447-1010
Executives
- Chairman of the Board, President, Chief Executive Officer
- Robert Bradway
- Chief Financial Officer, Executive Vice President
- Peter Griffith
- Executive Vice President, Chief Technology Officer
- David Reese
- Executive Vice President, Research and Development, and Chief Scientific Officer
- James Bradner
- Executive Vice President, General Counsel, Secretary
- Jonathan Graham
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $168.8B |
|---|---|
Revenue (TTM) | $29.5B |
Shares Outstanding | 536.4M |
Dividend Yield | 2.86% |
Annual Dividend Rate | 9.0000 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-07-24 |
Beta | 0.61 |
EPS | $7.00 |
Book Value | $11.64 |
P/E Ratio | 45.0x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | 20.3x |
Operating Margin | 23.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
